corresponding position is unexpectedly high and promoted
this cyclization.
Scheme 2. Indole Derived Structures
This direct acid catalyzed cyclization provided a fast and
efficient way for the preparation of multisubstituted indoles
which may have the potential to be transformed to many
privileged structures. Considering this, the conditions and
scale of this reaction were further investigated. Compound
2a was first used as the model substrate to optimize the
reaction conditions as shown in Table 1. Strong inorganic
and organic acids were used as catalysts and it was found
TFA in THF gave higher yield. When the solvent was
changed from THF to CH2Cl2, the reaction could finish at
room temperature and the yield could reach 92%. The
reaction finished very fast with 5.0 equiv of TFA (entry 5),
but the yield was low due to the formation of some
unidentified byproducts. Then TFA load was lowered to 1.3
equiv and excellent yield was obtained (entry 6). After
determining the optimized conditionsTFA (1.3 equiv),
CH2Cl2 (0.1 M solution for substrate) at room temperatureswe
tried to examine the substrate scope of the reaction. The
substrates for the cyclization were prepared by reaction of
2,4-difluoro-1,5-dinitrobenzene or 2,4-difluoronitrobenzene
with amines in a separated substitute procedure or a one pot
method according to the literature.6 With all the other
substrates, however, the reaction did not go to completion,
even with prolonged reaction time under the above optimized
condition. When more TFA was loaded (5.0 equiv), a better
result could be obtained. Substrates with different substitu-
tions on amino group were tried for cyclization as shown in
Table 2. Good to excellent yields for the isolated products
were achieved. We also tried to use ethoxy and ethylthio to
replace one of the amino groups to see if the molecules can
also undergo this cyclization, but unfortunately, no corre-
sponding product was found.
Encouraged by the above results, we initiated further
investigation to explore the possibility of preparing other
privileged structures derived from indoles prepared from the
above cyclizations. o-Nitroanilines are versatile substrates
for the construction of benzofused heterocycles.7 It will be
a useful method for the preparation of many indole fused
heterocycles with bioactive interests. Reduction of the nitro
groups of compounds 3f and 3g followed by cyclization,
compounds 5 and 6 were successfully obtained in yields of
79 and 43%, respectively (Scheme 2). Indole-4,7-quinones
were reported to have various bioactivities.8 Indole quinone
diimine is an isostere of indole quinone, it may also have
various activities and expands the diversity of the scaffold,
but no synthetic route to it has been reported. Reduction of
the nitro groups of compound 3a, and left the reaction
mixture exposed to the air, indole quinone diimine 7 was
successfully obtained in 49% yield.
In conclusion, we have developed a method for the
preparation of 2,3-unsubstituted nitro containing indoles from
commercially available 2,4-difluoro-1,5-dinitrobenzene or
2,4-difluoronitrobenzene and 2-aminoacetaldehyde dimethy-
lacetal (or its N-substituted derivatives) under mild condi-
tions. The nitro groups of resulting indoles can be reduced
and then further transformed to other indole fused structures
or indole quinone diimines, that are useful for the construc-
tion of biologically interesting molecules.
Acknowledgment. We are grateful to The Global Alliance
for TB Drug Development (TB alliance) for their financial
support.
Supporting Information Available: Detailed synthetic
1
procedures, characterization data, and H NMR, 13C NMR
of synthesized compounds. This material is available free
OL8027187
(8) (a) Ryu, C. K.; Lee, J. Y.; Park, R. E.; Ma, M. Y.; Nho, J. H. Bioorg.
Med. Chem. Lett. 2007, 17, 127–131. (b) Marminon, C.; Gentili, J.; Barret,
R.; Nebois, P. Tetrahedron 2007, 63, 735–739. (c) Legentil, L.; Lesur, B.;
Delfourne, E. Bioorg. Med. Chem. Lett. 2006, 16, 427–429. (d) Tapia, R. A.;
Prieto, Y.; Pautet, F.; Walchshofer, N.; Fillion, H.; Fenet, B.; Sarciron, M. E.
Bioorg. Med. Chem. 2003, 11, 3407–3412. (e) Jackson, Y. A.; Billimoria,
A. D.; Sadanandan, E. V.; Cava, M. P. J. Org. Chem. 1995, 60, 3543–
3545.
(6) Liu, G.; Fan, Y.; Carlson, J. R.; Zhao, Z. G.; Lam, K. S. J. Comb.
Chem. 2000, 2, 467–474.
(7) Zhang, L.; Liu, G.; Zhang, S. D.; Yang, H. Z.; Li, L.; Wu, X. H.;
Yu, J.; Kou, B. B.; Xu, S.; Li, J. J. Comb. Chem. 2004, 6, 431–436.
Org. Lett., Vol. 11, No. 3, 2009
639